Haleon Plc Spon Ads (HLN)

$8.51

Market is closed - opens 7 PM, 21 May 2024

Insights on Haleon Plc Spon Ads

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 2.76B → 2.91B (in $), with an average increase of 5.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -3.0M → 423.0M (in $), with an average increase of 100.7% per quarter

  • Vs NBIX

    In the last 1 year, Neurocrine Biosciences Inc. has given 51.3% return, outperforming this stock by 52.9%

Performance

  • $8.50
    $8.61
    $8.51
    downward going graph

    0.12%

    Downside

    Day's Volatility :1.22%

    Upside

    1.1%

    downward going graph
  • $7.60
    $8.80
    $8.51
    downward going graph

    10.69%

    Downside

    52 Weeks Volatility :13.64%

    Upside

    3.3%

    downward going graph

Returns

PeriodHaleon Plc Spon AdsIndex (Russel 2000)
3 Months
2.78%
0.0%
6 Months
3.15%
0.0%
1 Year
-0.47%
0.0%
3 Years
14.84%
-19.9%

Highlights

Market Capitalization
38.2B
Book Value
$1.8
Dividend Share
0.0
Dividend Yield
2.54%
Earnings Per Share (EPS)
0.29
PE Ratio
28.86
PEG Ratio
1.69
Wall Street Target Price
9.77
Profit Margin
9.64%
Operating Margin TTM
22.44%
Return On Assets TTM
4.28%
Return On Equity TTM
6.7%
Revenue TTM
11.2B
Revenue Per Share TTM
2.44
Quarterly Revenue Growth YOY
-2.1999999999999997%
Gross Profit TTM
6.7B
EBITDA
2.6B
Diluted Eps TTM
0.29
Quarterly Earnings Growth YOY
0.1
EPS Estimate Current Year
0.46
EPS Estimate Next Year
0.51
EPS Estimate Current Quarter
0.11
EPS Estimate Next Quarter
0.09

Analyst Recommendation

Buy
    64%Buy
    32%Hold
    4%Sell
Based on 25 Wall street analysts offering stock ratings for Haleon Plc Spon Ads(by analysts ranked 0 to 5 stars)
Based on 25 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
16
16
17
Hold
8
8
7
Sell
1
1
2

Analyst Forecast

What analysts predicted

Upside of 14.81%

Current $8.51
Target $9.77

Company Financials

FY19Y/Y Change
Revenue
11.1B
-
Net Income
858.9M
-
Net Profit Margin
7.72%
-
FY20Y/Y Change
Revenue
13.5B
↑ 16.65%
Net Income
1.6B
↑ 74.81%
Net Profit Margin
11.58%
↑ 3.86%
FY21Y/Y Change
Revenue
12.9B
↓ 3.51%
Net Income
1.9B
↑ 21.4%
Net Profit Margin
14.56%
↑ 2.98%
FY22Y/Y Change
Revenue
10.9B
↑ 13.76%
Net Income
1.1B
↓ 23.74%
Net Profit Margin
9.76%
↓ 4.8%
FY23Y/Y Change
Revenue
14.4B
↑ 4.09%
Net Income
1.3B
↓ 1.04%
Net Profit Margin
9.28%
↓ 0.48%
Q4 FY22Q/Q Change
Revenue
3.8B
↑ 31.15%
Net Income
198.0M
↓ 42.61%
Net Profit Margin
5.22%
↓ 6.71%
Q1 FY23Q/Q Change
Revenue
3.7B
↓ 21.28%
Net Income
481.9M
↑ 96.46%
Net Profit Margin
13.03%
↑ 7.81%
Q2 FY23Q/Q Change
Revenue
3.5B
↓ 7.84%
Net Income
375.9M
↓ 23.39%
Net Profit Margin
10.83%
↓ 2.2%
Q3 FY23Q/Q Change
Revenue
2.8B
↑ 1.67%
Net Income
365.0M
↑ 22.48%
Net Profit Margin
13.05%
↑ 2.22%
Q4 FY23Q/Q Change
Revenue
3.5B
↓ 1.14%
Net Income
-3.8M
↓ 100.82%
Net Profit Margin
-0.11%
↓ 13.16%
Q1 FY24Q/Q Change
Revenue
2.9B
↑ 5.53%
Net Income
423.0M
↓ 14200.0%
Net Profit Margin
14.49%
↑ 14.6%
FY19Y/Y Change
Total Assets
46.8B
-
Total Liabilities
10.9B
-
FY20Y/Y Change
Total Assets
46.5B
↓ 4.43%
Total Liabilities
10.8B
↓ 4.72%
FY21Y/Y Change
Total Assets
46.5B
↑ 0.94%
Total Liabilities
10.8B
↑ 0.81%
FY22Y/Y Change
Total Assets
34.8B
↑ 1.06%
Total Liabilities
18.4B
↑ 130.31%
FY23Y/Y Change
Total Assets
43.4B
↓ 2.18%
Total Liabilities
22.1B
↓ 5.62%
Q4 FY22Q/Q Change
Total Assets
11.5B
-
Total Liabilities
11.5B
-
Q2 FY23Q/Q Change
Total Assets
43.1B
-
Total Liabilities
22.2B
-
Q4 FY23Q/Q Change
Total Assets
43.4B
-
Total Liabilities
22.1B
-
FY19Y/Y Change
Operating Cash Flow
1.0B
-
Investing Cash Flow
381.6M
-
Financing Cash Flow
-1.2B
-
FY20Y/Y Change
Operating Cash Flow
1.9B
↑ 79.01%
Investing Cash Flow
1.4B
↑ 253.95%
Financing Cash Flow
-3.3B
↑ 163.46%
FY21Y/Y Change
Operating Cash Flow
1.8B
↓ 3.62%
Investing Cash Flow
-44.5M
↓ 103.2%
Financing Cash Flow
-1.7B
↓ 49.28%
FY22Y/Y Change
Operating Cash Flow
2.1B
↑ 52.14%
Investing Cash Flow
-8.8B
↑ 26518.18%
Financing Cash Flow
6.9B
↓ 659.14%
Q1 FY21Q/Q Change
Operating Cash Flow
161.3M
-
Investing Cash Flow
319.1M
-
Financing Cash Flow
-493.5M
-
Q2 FY21Q/Q Change
Operating Cash Flow
470.2M
↑ 190.6%
Investing Cash Flow
-5.9B
↓ 1954.64%
Financing Cash Flow
5.9B
↓ 1293.58%
Q1 FY22Q/Q Change
Operating Cash Flow
446.7M
↑ 0.0%
Investing Cash Flow
-5.6B
↑ 0.0%
Financing Cash Flow
5.6B
↑ 0.0%
Q2 FY22Q/Q Change
Operating Cash Flow
824.9M
↑ 100.0%
Investing Cash Flow
-10.4B
↑ 100.0%
Financing Cash Flow
10.4B
↑ 100.0%
Q4 FY22Q/Q Change
Operating Cash Flow
61.0M
↓ 91.03%
Investing Cash Flow
-8.8B
↑ 2.29%
Financing Cash Flow
6.9B
↓ 19.13%
Q2 FY23Q/Q Change
Operating Cash Flow
944.9M
↑ 1127.87%
Investing Cash Flow
-237.2M
↓ 97.86%
Financing Cash Flow
-855.3M
↓ 109.81%

Technicals Summary

Sell

Neutral

Buy

Haleon Plc Spon Ads is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Haleon Plc Spon Ads
Haleon Plc Spon Ads
1.79%
3.15%
-0.47%
14.84%
14.84%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
6.46%
30.03%
52.18%
50.78%
85.56%
Zoetis Inc.
Zoetis Inc.
19.6%
-1.14%
-3.04%
-0.99%
70.28%
Viatris Inc.
Viatris Inc.
-2.4%
15.95%
15.95%
-29.57%
-32.8%
Catalent, Inc.
Catalent, Inc.
-1.21%
38.67%
47.61%
-46.57%
22.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Haleon Plc Spon Ads
Haleon Plc Spon Ads
28.86
28.86
1.69
0.46
0.07
0.04
0.03
1.8
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
38.56
38.56
0.44
4.12
0.18
0.1
NA
23.72
Zoetis Inc.
Zoetis Inc.
33.47
33.47
2.58
5.77
0.5
0.14
0.01
11.07
Viatris Inc.
Viatris Inc.
224.4
NA
NA
2.74
0.0
0.03
0.04
16.81
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.06
0.37
-0.28
-0.01
NA
19.96
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$38.2B
14.84%
28.86
9.64%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$14.3B
85.56%
38.56
18.65%
Zoetis Inc.
Zoetis Inc.
Buy
$79.3B
70.28%
33.47
27.38%
Viatris Inc.
Viatris Inc.
Hold
$13.1B
-32.8%
224.4
-0.37%
Catalent, Inc.
Catalent, Inc.
Hold
$10.0B
22.04%
211.02
-28.44%

Institutional Holdings

  • Dodge & Cox

    2.42%
  • FMR Inc

    1.40%
  • ClearBridge Advisors, LLC

    0.58%
  • Harding Loevner L.P.

    0.49%
  • Fisher Asset Management, LLC

    0.32%
  • Wellington Management Company LLP

    0.30%

Corporate Announcements

  • Haleon Plc Spon Ads Dividends March,2024

    In the quarter ending March,2024. Haleon Plc Spon Ads has declared dividend of $0.11

    Read More

Company Information

Organization
Haleon Plc Spon Ads
Employees
25408
CEO
Mr. Brian James McNamara
Industry
Healthcare

FAQs